an independent news feed from Current Medicine Group™
- Latest oncology research
- Clinical trials
- Healthcare initiatives
- Practice guidelines
-
- Mar 15, 2010
- IMRT versus RapidArc – superiority depends on PTV For men undergoing radiotherapy of the prostate, conventional intensity-modulated radiotherapy performs better than RapidArc in dose sparing of the bladder, rectum, and small bowel for planning target volumes that include the prostate, seminal vesicles, and lymph nodes, researchers report.
-
- Mar 15, 2010
- External sphincter temperature predicts voiding function after cryoablation Patients who have an external sphincter temperature of 23°C or less during cryoablation are significantly more likely to experience urgency and/or frequency of urinary retention after cryoablation, study findings show.
-
- Mar 12, 2010
- PSA fall after antibiotics does not indicate absence of prostate cancer Patients with type IV prostatitis and high prostate-specific antigen levels are equally likely to show a decrease in the marker whether they receive antibiotics or placebo, researchers report.
-
- Mar 12, 2010
- Tumor percentage involvement, prostate volume predict PSA recurrence Tumor percentage involvement and prostate volume are independent predictors for prostate-specific antigen recurrence, but tumor volume is not, researchers report.
-
- Mar 11, 2010
- Reovirus shows potential as therapeutic approach in prostate cancer Reovirus therapy may provide a promising novel treatment for prostate cancer, researchers report.
-
- Mar 10, 2010
- CI adversely affects postop prognosis in patients with prostate cancer Capsular incision adversely affects the prognosis of patients with prostate cancer who have undergone radical perineal prostatectomy, researchers report.
-
- Mar 10, 2010
- Prostate cancer treatment choice varies with type of specialist consulted The prostate cancer treatment a man chooses depends greatly on the type of specialists he consults, researchers report.
-
- Mar 9, 2010
- Sarcosine fails as marker for prostate cancer detection Patients with and without prostate cancer cannot be differentiated by the levels of sarcosine in their urine following rectal digital examination, researchers report.
-
- Mar 8, 2010
- ERG/ETVI and PTEN gene loci identify death risk in prostate cancer patients Patients at low and high risk for death from prostate cancer can be identified by the presence or absence of the phosphatase and tensin homolog gene and gene rearrangements in
-
- Mar 8, 2010
- Increasing hospital admission rate for complications after TRUS-guided biopsy The hospital admission rates for complications following transrectal ultrasound-guided prostate biopsy increased dramatically between 1996 and 2005 in Ontario, Canada, and this is primarily due to an increasing rate of infection-related complications, researchers report.
Not signed in
Information
This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below.
Subscribe to RSS News Feed